Paradise Moon Fund sold 2,06,400 shares of Quest Laborato. for ₹2.01 Cr at ₹97.45 apiece in a bulk deal.
A pharmaceutical manufacturer incorporated in 1998, Quest Laboratories specializes in producing medicines across diverse therapeutic segments to serve the Indian healthcare market. The company develops and delivers pharmaceutical products addressing various medical conditions through research-driven formulations. Quest Laboratories operates as a vertically integrated manufacturer committed to pharmaceutical innovation, quality standards, and making healthcare solutions accessible to patients across India.
Launched in 2024 by Naveen Bansal (IIM-Calcutta, 15+ years in MSME) targeting Rs 750 cr over time. Dedicated to anchoring SME IPOs and capturing pre and post-listing gains in India's small business segment. Custodian: Nuvama.